Summit Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Summit Therapeutics stock have an average target of 33.33, with a low estimate of 23 and a high estimate of 44. The average target predicts an increase of 86.51% from the current stock price of 17.87.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$23	$33.33	$32	$44
Change	+28.71%	+86.51%	+79.07%	+146.22%

Analyst Ratings

The average analyst rating for SMMT stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	2	3	2	2	2	3
Buy	0	0	0	0	1	2
Hold	0	0	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	3	3	3	4	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mohit Bansal Wells Fargo	Wells Fargo	Buy Initiates $30	Buy	Initiates	$30	+67.88%	Dec 11, 2024
Brent Thill Jefferies	Jefferies	Strong Buy Initiates $31	Strong Buy	Initiates	$31	+73.48%	Dec 6, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $44	Strong Buy	Reiterates	$44	+146.22%	Nov 18, 2024
Reni Benjamin JMP Securities	JMP Securities	Buy Initiates $32	Buy	Initiates	$32	+79.07%	Nov 4, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $45 → $44	Strong Buy	Maintains	$45 → $44	+146.22%	Oct 31, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.30

from -0.99

EPS Next Year

-0.42

from -0.30

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	810.55K	860.00K	1.81M	705.00K	-	-	-	-14.47M
Revenue Growth	-98.58%	6.10%	110.35%	-61.03%	-	-	-	-
EPS	-0.97	-0.76	-0.96	-0.41	-0.99	-0.30	-0.42	-0.61
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	n/a	n/a	15.9M
Avg	n/a	n/a	-14.5M
Low	n/a	n/a	-81.2M

Revenue Growth

Revenue Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2024	2025	2026
High	-0.24	-0.34	-0.40
Avg	-0.30	-0.42	-0.61
Low	-0.30	-0.51	-0.79

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.